Unique PBM Capabilities

Similar documents
Growth in an Evolving Health Care Market

Meeting the Health Care Challenges of Tomorrow. Jon Roberts Executive Vice President & President, CVS Caremark

Delivering Value for All Health Care Stakeholders. Larry Merlo President & Chief Executive Officer

Third Quarter 2017 Earnings Conference Call

Fourth Quarter 2018 Earnings Conference Call

Fourth Quarter 2017 Earnings Conference Call

Evolving Health Care Market

Second Quarter 2017 Earnings Conference Call

Fourth Quarter 2016 Earnings Conference Call

Q Formulary Performance:

Earnings. Larry Merlo. President & Chief Executive Officer. Executive Vice President & Chief Financial Officer. November 4, 2014

SILVERSCRIPT S MEDICARE PART D PRESCRIPTION DRUG PLAN (PDP) FOR 2018

Insightsfeature. Managing Specialty Drug Spend Under the Medical Benefit. Innovations and Automation for More Effective Management.

Employer Group Waiver Plan (EGWP) FAQs

THANK YOU SPONSORS 2

How Medication Adherence and Outcomes Are Changing the Business Model

Pay for Performance & the Changing Landscape for Pharmacy: A Panel Discussion

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:

Pharmacy Program Management: Pitfalls, Challenges, and Best Practices About Solid Benefit Guidance specialty 60,000,000 covered member lives INSIDER

What to Expect for Pharmacy Benefits and Drug Cost Trends for 2018 & 2019

June Investor Presentation

CBI 4th Reimbursement and Contracting Conference: Key Challenges Related to Specialty Drug Pricing and Contracting

National Grid Retiree Club Meeting Long Island. October 2, 2017

2019 Transition Policy and Procedure

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:

Earnings Conference Call

Investor Conference. Health Net Pharmaceutical Services

Payer Channel Forecasting and Analysis. Patrick J. Park, PharmD, MBA Director, Business Decision Support Daiichi Sankyo, Inc.

Savings Generated by New York s Medicaid Pharmacy Reform

Managing Specialty Pharmaceuticals: Balancing Access and Affordability

PERACARE PLAN DESIGN CONSIDERATIONS JANUARY 18, 2019 JESSICA LINART, DIRECTOR OF INSURANCE

2019 Transition Policy

DIR: Trends, Issues, and Impending Impacts

PLAN F MEDICARE (PART A) HOSPITAL SERVICES PER BENEFIT PERIOD 2019

At the heart Annual Report. of health.

DIR fees are knocking down pharmacy profits

Medicaid Prescribed Drug Program Spending Control Initiatives. For the Quarter April 1, 2014 through June 30, 2014

Standing strong for payers and patients

Marc Claussen, Chiesi USA, Director, Market Access. Donna White, Chiesi USA, Sr. Director, Contracting and Compliance

36 th Annual J.P. Morgan Healthcare Conference January 9, Bruce D. Broussard President & CEO

The Declining Value of Payer Access: Defining and improving Rebate Efficiency in the current healthcare landscape

Medicaid Prescribed Drug Program. Spending Control Initiatives

A VISIBLY DIFFERENT APPROACH TO PHARMACY BENEFITS FOR EMPLOYERS

2018 Medicare Part D Transition Policy

M and A Activity Shakes Up PDP Leader Board

Medicare Transition POLICY AND PROCEDURES

Your Pharmacy Benefits Handbook

Challenges in High Dollar Drugs. Suzanne Francart, PharmD, BCPS Manager Infusion Services & Medication Assistance Program UNC HealthCare

Medicare Part D Transition Policy

Fresno Unified School District

2010 Summary of Benefits S5601

CVS HEALTH CORP FORM 10-K. (Annual Report) Filed 02/11/14 for the Period Ending 12/31/13

Contract Summary. OptumRx Administrative Services, LLC

White Paper: Formulary Development at Express Scripts

The Real Deal About Real-Time Benefits. Proven Savings with Up-to-the-Minute, Member-Specific Information Across Multiple Points of Care

Understanding PBM Quality. The 2 nd National Alliance PBM Report. John Miller

CIS Responses to Vendor Questions PBM RFP September 23, 2015 Addendum #1

Employer Group Plans Drive Medicare PDP Growth

Highlights of the Group Retiree Medical Plan for Schools Insurance Group Retirees

Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule

BERKELEY RESEARCH GROUP. Executive Summary

PLAN F MEDICARE (PART A) HOSPITAL SERVICES PER BENEFIT PERIOD

CFA Society of Minnesota

Medicare Part D Transition Policy CY 2018 HCSC Medicare Part D

PLAN F or HIGH DEDUCTIBLE PLAN F MEDICARE (PART A) HOSPITAL SERVICES PER BENEFIT PERIOD

The Management of Specialty Drugs: Opportunities and Challenges

Martin s Point Generations Advantage Policy and Procedure Form

Medicare Advantage Part D Pharmacy Policy

Highlights of the Group Medicare Prescription Drug Plan. Administrative Services from Group Administrative Concepts

Pharmacy Benefit Managers (PBMs)

JP Morgan 27th Annual Healthcare Conference Angela F. Braly President & Chief Executive Officer January 12, 2009

New Health Plan Cost Strategies for the City of Fort Worth. TMHRA Annual Forum May 2, 2018

A VISIBLY DIFFERENT APPROACH TO PHARMACY BENEFITS FOR GOVERNMENT

PhRMA Perspective: Government Policies to Support Innovative Contracting Approaches

PRESCRIPTION DRUG SPENDING IN THE U.S. HEALTH CARE SYSTEM: AN ACTUARIAL PERSPECTIVE

South Dakota. Medicare Drug Plan Ratings. Analytics by Avalere Health

TRS-Care Enrollment Guide for Medicare Eligible Retirees. Sept. 1, Dec. 31, 2017

Federal Spending on Brand Pharmaceuticals. April 2011

Magellan Health. Cantor Fitzgerald Healthcare Conference September 26, 2017

Consistent with current practice, pharmacies will be paid by a member s plan, subject to its rules, formulary, and rates:

2018 Transition Fill Policy & Procedure. Policy Title: Issue Day: Effective Dates: 01/01/2018

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter April 1, 2016 through June 30, 2016

Common Managed Care Terms & Definitions

Medicare Overview Employer Options and Trends

Contents General Information General Information

Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy

MEDICARE PART D POLICY FORMULARY: TRANSITION PROCESS Policy Number: 6-C

Medicare Modernization Act (MMA)

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter July 1, 2016 through September 30, 2016

Medicare Part D in 2018: The Latest on Enrollment, Premiums, and Cost Sharing

Idaho. Medicare Drug Plan Ratings. Analytics by Avalere Health

Impact of H.R. 1038/S. 413 on CMS Payments Under Part D

How the Blueprint Policy Statement to Lower Drug Costs and Reduce Out-of- Pocket Costs May Affect Employers

TRANSITION POLICY. Members Health Insurance Company

Projected Impacts of Adopting a Pharmacy Carve-In Approach Within Medicaid Capitation Programs

Y0076_ALL Trans Pol

ECONOMIC PRINCIPLES IMPACTING MANAGED CARE PHARMACY. Adrian Washington PharmD., MBA Vice President of Client Management United Healthcare OptumRx

Information Memorandum Transmittal

Washington. Medicare Drug Plan Ratings. Analytics by Avalere Health

An Overview of the Medicare Part D Prescription Drug Benefit

Transcription:

Gaining Lives With Our Unique PBM Capabilities Jon Roberts Executive Vice President & President, CVS/caremark

Agenda Performance Highlights Pharmacy Trends and Cost Management Programs Well Positioned to Grow in Evolving Health Care Environment 2

Delivering on Our Promises with Strong PBM Performance Net Revenue ($, billions) Operating Profit ($, billions) 13.6% CAGR 98.2 14.6% CAGR 3.8 76.2 3.1 58.9 2.2 2011 2013 2015E 2011 2013 2015E Notes: 1. 2013 excludes Provigil. 2. 2015 reflects midpoint of guidance ranges. 3

2015 Gross New Business of $6.6 Billion State of Florida $1.3 billion $6.6 billion $2.1 billion $3.2 billion Health Plan Government & Union Employer Notes: 1. As of 12/4/14. 2. Gross Wins excludes Medicare Part D SilverScript individual products. 4

Net New Client Business of $3.2 Billion with 96% Retention 6.6 1.8 Revenues ($, billions) 75% of client nonrenewals due to acquisition and retirees 0.8 0.8 3.2 Business Not Renewed Gross New Business Acquired Moved to Exchange (Primarily Retirees) Other Net New Business 4 million members implemented in 2014 clients highly satisfied Notes: 1. As of 12/4/14. 2. Net New Client Business excludes Medicare Part D SilverScript individual products. 3. Client retention rate is defined as: 1 less (projected 2015 lost revenues from known terminations occurring after January 1, 2014, divided by estimated 2015 PBM revenues) expressed as a percentage. Both terminations and PBM revenues exclude the individual PDP business. 5

How We Win: Compete on Price, Differentiate with Service and Capabilities Exclusive Specialty Network Strategies Preferred Network, Maintenance Choice Advanced Formulary Strategies Adherence Programs 6

Aetna: Continuing to Expand Our Partnership Aetna Medicare Coventry Commercial Business and Medicaid d Q1 2015 Q1 2016 2017 Coventry Medicare Maintenance Choice and Pharmacy Advisor continue to expand Note: 1. Aetna Medicare Business lives are moving to the CVS/caremark platform in Q1 of 2015. 7

Maintenance Choice : Client and Member Value Drive Continued Adoption Maintenance Choice Adoption (members, millions) ~34 20 to 21 10.8 2.9 2009 2012 2015E Runway Maintenance Choice 1.0 Maintenance Choice 2.0 Note: 1. Maintenance Choice 1.0 includes Mandatory, Mandatory Opt-Out and Incentive based. 8

Specialty Connect TM : Like Maintenance Choice, Only CVS Health Can Offer Counseling From Choose Where to Choose Preferred Therapy-specific Send / Bring Prescription CareTeams Delivery Location CVS/specialty Home / Location of Choice CVS/pharmacy Full Integration With CVS/specialty CVS/pharmacy ~75,000 patients served half choose the retail pick-up option 9

Pharmacy Advisor Serves All Our Lines of Business Cumulative Counseling Interventions (millions) 9.9 1.3 3.8 7.2 Q4'11 Q4'12 Q4'13 Q3'14 Successfully deployed d across Commercial, Medicare and Medicaid Delivering value in Medicare on Clinical Star Measures Retail Call Center Note: 1. PBM: Commercial, Medicare, Medicaid and Exchanges. 10

CVS/minuteclinic Savings Strategy Continues to Grow Client Adoption (members, thousands) 14,500 ~14 fold increase in member lives enrolled in three years ~14X 1,200 Launched capability to adjudicate CVS/minuteclinic services through PBM benefit 239 88 108 2012 2013 2014 2015 Runway Significant opportunity to grow lives with CVS/minuteclinic remains 1.2 million total implemented and committed lives to date Note: 1. CVS Caremark Product Team master client pipeline tracking. Based on implemented plans thru 2014. 11

Enterprise Share: ~40% of PBM Prescriptions Through CVS Health Channels CVS Health Share of CVS/caremark Prescriptions 58% 40% 28% Book of Business Employer Health Plan Opportunity to drive additional enterprise share with health plans Note: 1. Enterprise share (includes mail) for the nine months ended September 2014. 2. Book of Business includes Medicare Part D SilverScript individual products. 12

Agenda Performance Highlights Pharmacy Trends and Cost Management Programs Well Positioned to Grow in Evolving Health Care Environment 13

Fewer New Generics to Mitigate Trend: Spend Management Programs Increase in Importance Total Brand Market Sales of Expected Generic Launches ($, billions) 35.0 24.4 14.7 16.5 12.3 5.8 2012 2013 2014E 2015E 2016E 2017E Note: 1. 2013 and prior includes all actual launches. 2. 2014E forward includes all actual and expected generic launches in total brand numbers. 3. Forward-looking information assumes no at risk launches. Source: Total brand market sales estimates represent 12 months of sales as reported in the IMS Health NSP file. 14

Specialty is Growing in Absolute Dollars and Percent of Total Spend Total Industry Specialty Spend ($, billions) 179 235 92 127 17% CAGR 2012 2014E 2016E 2018E Specialty 30% 38% 45% 50% Percent of Total Drug Spend Pharmacy spend Medical spend Infused oncology Source: NHE, Artemetrix, CVS/caremark internal analysis, 2013. 15

Return of Double-digit Trend Requires Tighter Cost Controls Payor Trend 10.3% 3.8% 0.1% 2012 2013 2014E Source: 2014 - Enterprise Analytics as of Q314; excludes compounds due to client-specific strategies. 16

Our Unique Set of Tools to Manage Trend Traditional / Non-specialty Drugs Specialty Drugs In Pharmacy Specialty Drugs In Medical Formulary Managed, Advanced, Value Advanced Specialty Networks 30- and 90-day Retail, Mail, Maintenance Choice Preferred, Exclusive and Infusion Networks Utilization Management Prior Authorization, Retrospective review Cross-Benefit Clinical Guideline Management and PA Site Of Care Site of Care Transition Management with Coram Nurses Claims Editing Prior Authorization, Retrospective Review Pharmacy Benefit Claims Edits Medical Benefits Claims Edits with Novologix Technology Care Coordination Pharmacy Advisor CareTeam including Pharmacist, Accordant and Coram Nurses 17

A Closer Look: Our Formulary Options Save Clients Money and Drive Increased Use of Generics Managed Formulary CVS/caremark led industry with introduction of strategy to exclude certain branded drugs from formulary Approach delivers savings to clients and their members Improved rebates on formulary brands Increased penetration of generics Have excluded more drugs to date than other traditional PBMs Incremental savings of over $3.5 billion expected 12 through 15 Source: CVS/caremark internal data, 2014. 18

A Closer Look: Our Formulary Options Save Clients Money and Drive Increased Use of Generics Less Savings More Managed Formulary Advanced Formulary Value Formulary Client Savings 1% to 2% 3% to 5% 10% to 12% GDR Increase 05% 0.5% 10% 1.0% 8% to 10% Incremental savings of over $3.5 billion expected 12 through 15 Source: CVS/caremark internal data, 2014. 19

A Closer Look: Our Network Options Offer Savings and Choice Less Savings More Retail 90 Maintenance Choice 2.0 Maintenance Choice 1.0 90-day Network National Advanced Choice TM Exclusive Choice 30-day Network 68,000 50,000 19,000 pharmacies pharmacies pharmacies 20

Agenda Performance Highlights Pharmacy Trends and Cost Management Programs Well Positioned to Grow in Evolving Health Care Environment 21

Evolving Health Care Environment: Consumer is at the Center 150% 3X growth in CDH enrollment CONSUMERS expected covered lives by 2018 10K 40+% people per day turning 65 projected increase in lives from 2013 Source: CDH - Employer Health Benefits Survey 2014; Exchanges - CBO 2014 beginning with 2013 enrollment; Medicaid Avalere 2014; Medicare: Pew Research Center. 22

Five Factors Positioning Us for Solid Growth Positioned To Grow With Our Integrated t Assets and Deep Expertise 1 2 3 4 5 Only CVS Differentiated Member Experience Growth in Government Programs: Medicare and Medicaid Winning With Health Plans Supporting Providers in New Reimbursement Models Exceptional Service Investing for the Future 23

Only CVS Differentiated Member Experience: Helps Members Better Manage Health and Costs CVS Retail Pharmacist CVS/minuteclinic Nurse 1 Call Center Pharmacist CVS/specialty Care Team Benefit Opportunity Specialist Infusion Nurse Digital Tools 24

Growth in Government Programs: Medicare Growth Through SilverScript and Our Health Plan Partners 2 SilverScript Choice and SilverScript Plus Competitively priced Zero deductible and low premium Personalized marketing OptumRx Express Scripts Medicare Members By PBM (millions) 7.2 CVS Health 69 6.9 Humana Catamaran Cigna 1.6 Prime MedImpact Envision 0.7 0.4 1.5 3.9 6.3 Captive PDP Captive MAPD NonCaptive 8.4 Source: CMS (Membership figures as of October 3, 2014) 25

Growth in Government Programs: Medicare Membership Projected to be ~7.5 Million 2 January 2015 CVS/caremark Projected Medicare Members (millions) 0.4 0.2 7.5 6.9 2014 Medicare Members Individual PDP Health Plan & EGWPs 2015E Medicare Members Note: Preliminary projections on 12/8/14 after the close of the Medicare Annual Enrollment Period. 26

Growth in Government Programs: Increased Medicaid Enrollment with Lives Growth 2 Managed Medicaid Enrollment (lives, millions) 40+% 2015 Managed Medicaid PBM (estimated % of lives) 31.7 2.8 9.9 44.4 Other 34% Express Scripts 21% 2013 MCO Enrollment Increased Utilization of MCOs and Organic Growth New Enrollees from ACA Eligibility Expansion 2016 MCO Enrollment MedImpact 8% Prime 2% Catamaran 6% OptumRX 10% 19% Source: CVS/caremark analysis, Avalere September 2014. MCO = Managed Care Organization 27

Winning with Health Plans: $3.2 Billion Gross New Business and 30 Total Exchange Clients in 2015 3 Unique PBM Model Comprehensive services that meet needs for cost control, quality, enhanced capabilities Comprehensive Specialty Solutions Holistic approach to manage specialty pharmacy across both pharmacy and medical benefits Member Access and Engagement Enterprise services that create competitive advantage in the B2C environment Expertise in Government Programs Line of business expertise to drive growth, compliance and innovation 28

Supporting Providers in New Reimbusement Models: Patient-centered Medical Home Example 4 CVS/pharmacy Adherence counseling and Electronic Health Record notification of patient non-adherence and gaps in therapy CVS/caremark Pharmacists provide counseling on adherence and comprehensive medication review for vulnerable patients CVS/minuteclinic Support their patient management with programs such as diabetes counseling and smoking cessation Patient-centered Medical Home CVS/specialty CareTeam pharmacist and Accordant nurse serve as extension of clinical team 29

Supporting Providers in New Reimbusement Models: Patient-centered Medical Home Example 4 CVS/pharmacy Adherence counseling and Electronic Health Record notification of patient non-adherence and gaps in therapy CVS/caremark Pharmacists provide counseling on adherence and comprehensive medication review for vulnerable patients CVS/minuteclinic Support their patient management with programs such as diabetes counseling and smoking cessation Patient-centered Medical Home CVS/specialty CareTeam pharmacist and Accordant nurse serve as extension of clinical team 30

Exceptional Service: We re Raising the Bar to Ensure Continued Success 5 Continue to Evolve Service Culture Define success Make the metrics visible Reward achievement Invest in Infrastructure Integrated delivery channels Automated benefit builder Artificial intelligence in call centers Digital capabilities Monitor Performance Metrics Holistic view of operational performance Early detection of trends; avoidance of escalated issues Speedy resolution 31

Positioned for Today, Preparing for Tomorrow Made the Right Moves Investments and Innovations address payor needs Effectively engaging members and providers Winning in the marketplace with integrated model Still Only CVS Scale and expertise ensure competitive pricing i Differentiated offerings drive client retention and wins Looking Ahead Continued Innovation Continue to expand unique breadth of capabilities Partnering with health plans to meet their needs Sustainable Growth Unmatched capabilities to win in fast-growing sectors Positioned for sustainable growth as market evolves 2014 CVS Gaining Health Lives With Our Unique PBM Capabilities 32